BioAtla Income Statement (2020-2026) | BCAB

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
0.65M0.70M0.72M0.72M0.75M0.73M0.93M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.27M1.66M
Revenue & cost
Revenue (Quarter)
0.25M11.00M2.00M
Operating items
Research & Development (Quarter)
14.85M16.55M16.45M16.92M20.71M19.84M21.87M21.70M30.96M28.40M22.67M18.85M16.20M16.39M11.65M12.36M13.68M9.54M8.00M4.58M
Selling, General & Administrative (Quarter)
15.86M7.14M7.04M7.42M8.34M6.34M6.69M7.23M6.24M6.62M5.86M5.61M5.77M5.88M4.59M5.26M4.96M4.25M3.26M4.73M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
30.71M23.70M23.49M24.35M29.05M26.18M28.56M28.93M37.20M35.02M28.54M24.46M21.97M22.27M16.24M17.61M18.65M13.79M11.26M9.31M
Operating Income (Quarter)
-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M
EBIT (Quarter)
-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M
Non-operating items
Interest & Investment Income (Quarter)
0.08M0.08M0.10M0.09M0.15M0.37M1.05M1.48M1.46M1.73M1.64M1.22M0.90M0.69M0.55M0.40M0.23M0.13M0.07M0.04M
Other Non Operating Income (Quarter)
0.08M0.77M0.09M0.15M0.40M1.02M1.47M1.45M1.70M1.61M1.22M0.90M0.68M1.36M2.28M-0.06M-1.99M-0.53M2.96M
Non Operating Income (Quarter)
-0.00M0.00M0.01M0.00M0.03M-0.03M-0.01M-0.01M-0.04M-0.03M-0.01M-0.00M
Net income details
EBT (Quarter)
-45.58M-23.99M-23.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M
Profit After Tax (Quarter)
-30.38M-22.93M-23.39M-24.25M-28.91M-25.78M-27.54M-27.46M-35.75M-33.33M-26.93M-23.23M-21.07M-10.59M-14.88M-15.33M-18.71M-15.78M-9.78M-6.34M
Income from Continuing Operations (Quarter)
-45.58M-23.99M-23.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M
Consolidated Net Income (Quarter)
-45.58M-23.99M-23.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M
Income towards Parent Company (Quarter)
-45.58M-23.99M-23.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M
Net Income towards Common Stockholders (Quarter)
-30.38M-22.93M-23.76M-24.64M-91.08M-2759.50M-27.91M-27.86M-133.99M-34.13M-27.17M-472.87M-22.77M-11.85M-15.70M-17.50M-26.27M-15.28M-9.18M-9.29M
Additional items
EPS (Basic) (Quarter)
-45.10-33.81-34.38-33.01-121.69-0.00M-35.85-29.27-140.43-35.68-28.44-491.68-23.61-12.26-16.16-15.02-22.45-13.00-7.80-6.19
EPS (Diluted) (Quarter)
-45.10-33.81-34.38-33.01-121.69-0.00M-35.85-29.27-140.43-35.68-28.44-491.68-23.61-12.26-16.16-15.02-22.45-13.00-7.80-6.19
Shares Outstanding (Quarter)
0.67M0.68M0.69M0.75M0.75M0.75M0.78M0.95M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.50M
Shares Outstanding (Diluted) (Quarter)
0.67M0.68M0.69M0.75M0.75M0.75M0.78M0.95M0.95M0.96M0.96M0.96M0.96M0.97M0.97M1.16M1.17M1.17M1.18M1.50M
EBITDA (Quarter)
-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M-9.31M
Interest Expenses (Quarter)
15.20M0.37M0.37M0.38M62.17M2,733.69M0.40M0.41M98.25M0.84M0.27M449.64M1.69M1.27M0.01M0.29M7.86M1.62M0.02M